Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Breakthrough hope: Benitec Biopharma’s BB-301 delivers promising results in rare muscular dystrophy trial Find out how Benitec Biopharma’s BB-301 gene therapy is showing early success in restoring swallowing function for OPMD patients. bySoujanya RaviNovember 3, 2025